Low-density platelet populations demonstrate low in vivo activity in sporadic Alzheimer disease

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Platelets

• Publication date

  2012-02-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/09537104.2011.593654PMID 22150375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitochondrial γ‐secretase participates in the metabolism of mitochondria‐associated amyloid precursor protein

  2011cited by this paper
• Alzheimer’s disease is characterized by more low‐density erythrocytes with increased volume and enhanced β‐amyloid x‐40 content

  2011cited by this paper
• Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease

  2011cited by this paper
• Predictive Value of Platelet Activation for the Rate of Cognitive Decline in Alzheimer's Disease Patients

  2010cited by this paper
• Platelet Density Distribution in Essential Thrombocythemia

  2010cited by this paper
• Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro

  2010cited by this paper
• Rate of progression in Alzheimer's disease correlates with coated-platelet levels--a longitudinal study.

  2008cited by this paper
• Effects of ageing and Alzheimer's disease on mitochondrial function of human platelets.

  2008cited by this paper
• Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease.

  2008cited by this paper
• Correlation between Platelet Amyloid Precursor Protein Isoform Ratio and Cognition in Alzheimer's Disease

  2007cited by this paper
• Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology.

  2007cited by this paper
• Determinants of platelet activation in Alzheimer's disease.

  2007cited by this paper
• Coated-platelets retain amyloid precursor protein on their surface

  2006cited by this paper
• Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment.

  2006cited by this paper
• Coated-platelets: an emerging component of the procoagulant response.

  2005cited by this paper
• Identification of low-density platelet populations with increased reactivity and elevated alpha-granule content.

  2003cited by this paper
• Individual variations of platelet inhibition after loading doses of clopidogrel

  2002cited by this paper
• Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms

  2002cited by this paper
• Platelet APP isoform ratios correlate with declining cognition in AD

  2000cited by this paper
• The use of platelet density and volume measurements to estimate the severity of pre‐eclampsia

  2000cited by this paper
• Platelet density in essential thrombocythemia and polycythemia vera.

  1999cited by this paper
• Platelet Density and Size in Inflammatory Bowel Disease

  1996cited by this paper
• Computerised method for recording platelet density distribution

  1995cited by this paper
• Platelets Are the Primary Source of Amyloid β-Peptide in Human Blood

  1995cited by this paper
• Platelets are the primary source of amyloid beta-peptide in human blood.

  1995cited by this paper
• Adhesion efficiency, platelet density and size

  1992cited by this paper
• The amyloid precursor protein of Alzheimer's disease is released by human platelets.

  1990cited by this paper
• Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA.

  1990cited by this paper
• Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents.

  1984cited by this paper
• Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type.

  1980cited by this paper
• Heterogeneity of human platelets. V. Differences in glycolytic and related enzymes with possible relation to platelet age.

  1972cited by this paper
• Heterogeneity of Human Platelets III. GLYCOGEN METABOLISM IN PLATELETS OF DIFFERENT SIZES

  1970cited by this paper
• Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets.

  1969cited by this paper

• Heterogeneity of Single-platelet Calcium Responses to Activation

  2025cites this paper
• Diabetes type 2: relationships between lysosomal exocytosis of circulating normal-sized platelets and in vitro ɑ-thrombin-evoked platelet responses

  2023cites this paper
• β-Amyloid promotes platelet activation and activated platelets act as bridge between risk factors and Alzheimer's Disease.

  2022cites this paper
• Association of Peripheral Blood Cell Profile With Alzheimer's Disease: A Meta-Analysis

  2022cites this paper
• Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer's disease?

  2021cites this paper
• Small procoagulant platelets in diabetes type 2.

  2020cites this paper
• Protein Kinase Cɛ in the Platelet and Hippocampal Tissue as a Diagnostic Biological Marker in Alzheimer Disease

  2019cites this paper
• Very high-density platelets determine reactivity and activity of circulating platelets

  2018cites this paper
• Very high-density platelets determine reactivity and activity of circulating platelets

  2018cites this paper
• Inverse relationship between erythrocyte size and platelet reactivity in elderly

  2017cites this paper
• Association of Platelet Serotonin Levels in Alzheimer’s Disease with Clinical and Cerebrospinal Fluid Markers

  2016cites this paper
• Alzheimer and platelets: low-density platelet populations reveal increased serotonin content in Alzheimer type dementia.

  2014cites this paper
• Role of platelets in neurodegenerative diseases: a universal pathophysiology

  2013cites this paper
• P-selectin paradox and dementia of the Alzheimer type: Circulating P-selectin is increased but platelet-bound P-selectin after agonist provocation is compromised

  2013cites this paper
• Alzheimer′s disease and granulocyte density diversity

  2013cites this paper
• Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease.

  2013cites this paper
• Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease

  2013cites this paper
• Degenerative Neurological and Neuromuscular Disease Cell adhesion molecules in Alzheimer ’ s disease

  2012cites this paper
• Cell adhesion molecules in Alzheimer's disease.

  2012cites this paper